Use of low-molecular-weight heparins for preventing and treating central nervous system trauma

Details for Australian Patent Application No. 2002300292 (hide)

Owner Aventis Pharma S.A.

Inventors Uzan, Andre; Stutzmann, Jean-Marie; Wahl, Florence

Agent Davies Collison Cave

Pub. Number AU-A-2002300292

Parent 77759

Filing date 26 July 2002

Wipo publication date 19 December 2002

International Classifications

A61K 031/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

Event Publications

19 December 2002 Application Open to Public Inspection

  Published as AU-A-2002300292

22 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300294-Steering Apparatus In Vehicle And Industrial Vehicle

2002300291-Production Of Attenuated Parainfluenza Virus Vaccines From Cloned Nucleotide Sequences